EUCTR2011-006151-10-DK进行中（未招募）不适用
FAME - Fampyra outcome measures study: a study of responsiveness of different outcome measures to Fampyra treatment. - FAME
Sønderjylland Hospital, department of neurology0 个研究点开始时间: 2012年2月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with clinically definite multiple sclerosis diagnosed according to the McDonald criteria, aged 18-60 years, EDSS 4-7, pyramidal FS >= 2, able to transport self to University of Southern Denmark in Odense.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 125
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •History of epileptic seizures, relapses of multiple sclerosis or change in disease modifying therapy within 60 days, cancer within five years, uncontrolled hypertension or clinically important cardiac, hepatic, renal or pulmonary disease, pregnancy and concomitant tratment with cimetidine, carvedilol, propranolol or metformine.
研究者
相似试验
招募中
不适用
Improvement of quality of life of wives of alcoholics through family supportCTRI/2020/04/024568Mrs Shiji PJ
已完成
2 期
Effectiveness of Family-Based Interventions on Family Members of Bipolar PatientsBipolar Disorder.Bipolar affective disorderIRCT2017061434533N1Vice Chancellor for Research of Social Welfare and Rehabilitation Sciences University.60
尚未招募
不适用
An Observational study to assess the effect of fastfood available on streets on the status of Rasa dhatu(CVS)in youths(College going students).CTRI/2022/04/041675Vasundhara Ramesh Mahewar
进行中（未招募）
1 期
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaRelapsed/refractory B-cell non-Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2021-003272-13-NLCellPoint B.V.45
进行中（未招募）
1 期
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaEUCTR2021-003272-13-BECellPoint B.V.45